PDI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Perit Dial Int 13(Suppl_2): 190-191
1993
© 1993 International Society for Peritoneal Dialysis
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mora-Macia, J
Right arrow Articles by del Rio, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mora-Macia, J
Right arrow Articles by del Rio, G
Peritoneal Dialysis International, Vol 13, Issue Suppl_2, S190-S191
Copyright © 1993 by International Society for Peritoneal Dialysis


Articles

Atrial natriuretic factor in patients on continuous ambulatory peritoneal dialysis

J Mora-Macia, T Donate, J Ocon, M Roda, and G del Rio

Nephrology Service, Fundacion Puigvert, Barcelona, Spain.

The aim of this study was to compare the levels of the atrial natriuretic factor (ANF) and the renin system in patients on continuous ambulatory peritoneal dialysis (CAPD) with patients on chronic hemodialysis (HD). We studied three groups. The CAPD group comprised 10 patients (25-66 years); the HD group: 10 patients (35-69 years), before (pre-HD) and after (post-HD) a HD session. The control group comprised 10 subjects with normal renal function (29-65 years), matched for age, height, weight, and diastolic pressure with the CAPD group. Blood pressure (BP) and blood samples for plasma renin activity (PRA), plasma aldosterone (PA), and ANF were taken. The BP and levels of ANF, PRA and PA were: in the control group, 121 +/- 15/75 +/- 4 mmHg, 7.3 +/- 5.6 pmol/L, 1.1 +/- 0.8 ng/mL/hour, 0.4 +/- 0.3 nmol/L. In the CAPD group, 132 +/- 26/76 +/- 12 mmHg (NS), 8.3 +/- 3.5 pmol/L (NS), 5.6 +/- 4.4 ng/mL/hour (p < 0.001), 4.9 +/- 4.0 nmol/L (p < 0.001). In the pre-HD, 159 +/- 25/95 +/- 12 mmHg (p < 0.001), 16.0 +/- 8.5 pmol/L (p < 0.005), 11.99 +/- 9.0 ng/mL/hour (p < 0.001), 2.6 +/- 2.3 nmol/L (p < 0.001). In the post-HD, 145 +/- 29/84 +/- 15 mmHg (p < 0.05 vs CG), 13.4 +/- 6.9 pmol/L (p < 0.05 vs control), 14.9 +/- 10.3 ng/mL/hour (p < 0.001 vs control), 3.8 +/- 2.9 nmol/L (p < 0.001 vs control).(ABSTRACT TRUNCATED AT 250 WORDS)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 1993 by Multimed Inc.